Negara: Inggris
Bahasa: Inggris
Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)
Thyme; Marshmallow root
Omega Pharma Ltd
Thyme; Marshmallow root
8mg/1ml ; 55.33mg/1ml
Oral suspension
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 03090200; GTIN: 5012616262197 5012616262203 5012616262210
App Store. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE BUTTERCUP BRONCHOSTOP COUGH SYRUP Do not store above 25°C. Store in the original package in order to protect the contents from light. KEEP OUT OF THE SIGHT AND REACH OF CHILDREN. Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month. Close tightly after use. After opening, use within 4 weeks. Do not throw away medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures help protect the environment. 6. CONTENTS OF THE PACK AND OTHER INFORMATION WHAT BUTTERCUP BRONCHOSTOP COUGH SYRUP CONTAINS 15 ml of oral syrup (15.45 g) contains the actives substances: 120 mg of extract (as dry extract) from Thyme herb (_Thymus vulgaris_ L. and _Thymus zygis_ L.,herb ) (DER 7-13:1) extraction solvent: water 830 mg of extract (as liquid extract) from Marshmallow root (_Althaea officinalis_ L.) (DER 1:12-14) extraction solvent: water THE OTHER INGREDIENTS ARE: Maltodextrin, Acacia (E414), Xylitol (E967), Methyl parahydroxybenzoate (E218), Raspberry juice concentrate (containing sucrose, glucose and fructose), Xanthan gum, Citric acid monohydrate, Propyl parahydroxybenzoate (E216), Raspberry aroma flavouring (synthetic and natural flavourings, propylene glycol (E1520)), glycerol (E422), saccharin-sodium (E954), neohesperidin- dihydrochalcone, Purified water WHAT BUTTERCUP BRONCHOSTOP COUGH SYRUP LOOKS LIKE AND CONTENTS OF THE PACKAGE Buttercup Bronchostop Cough Syrup is a brown-red, viscous liquid. The syrup is contained in brown glass bottles with a sealed screw cap, in 120 ml, 200 ml and 240 ml sizes. Not all pack sizes may be marketed. The package includes a measuring cup with a scale from 2.5 ml to 20 ml which allows precise measuring of the recommended dose. THR HOLDER Omega Pharma Ltd, Wrafton, Braunton, Devon, EX33 2DL, UK MANUFACTURER Kwizda Pharma GmbH, Effinge Baca dokumen lengkapnya
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Buttercup Bronchostop Cough Syrup 2. QUALITATIVE AND QUANTATIVE COMPOSITION 15 ml of syrup (15.45 g) contains: 120 mg of extract (as dry extract) from Thyme herb (_Thymus vulgaris _L._ _and _Thymus _ _zygis _L., herb) (DER 7-13:1) extraction solvent: water and 830 mg of extract (as liquid extract) from Marshmallow root (_Althaea officinalis _L.) (DER 1:12-14) extraction solvent: water Excipient(s) with known effect: Each single dose (15 ml) contains 11.59 mg of methyl parahydroxybenzoate (E218), 6.18 mg of propyl parahydroxybenzoate (E216) and 131 mg total sugars from raspberry juice concentrate (containing sucrose, glucose and fructose) and 38.9 mg propylene glycol (E1520) contained in raspberry aroma flavour (See ‘Section 4.4 Special warnings and precautions for use’) For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral Syrup Brown-red, viscous liquid 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Traditional herbal medicinal product used for the relief of coughs, such as chesty coughs and dry, tickly, irritating coughs and catarrh based on traditional use only. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral use only. Adults, the elderly and children over 12 years: Using the measuring cup provided, 15 ml of syrup to be taken every 4 hours, 4 times per day. If required, up to a maximum of 6 doses (90ml) can be taken per day. _Method of administration: _ _ _ Buttercup Bronchostop Cough Syrup_ _may be administered undiluted or diluted in water or warm tea. This product is not recommended for use in children under 12 years of age (See ‘Section 4.4 Special warnings and precautions for use.’) _Duration of use:_ If symptoms worsen, or persist after 7 days, a doctor or a qualified healthcare practitioner should be consulted. 4.3 CONTRAINDICATIONS Hypersensitivity to marshmallow root, thyme, to other members of the Lamiaceae family or to any of the excipients listed in section 6.1. 4.4 SPECIAL WARNINGS AND PRECAUTION Baca dokumen lengkapnya